TrialMedicine2019

A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China.

Cheng Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.